Skip to main content
    V

    Vanda Pharmaceuticals Inc (VNDA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.81
    -0.18 (-4.51%)

    Market Cap: $241.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vanda Pharmaceuticals Inc (VNDA) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Net federal contract obligations to Vanda Pharmaceuticals were -$5,360 over the 12 months through Jul 31, 2026, as agencies removed more from existing contracts than they added. Vanda Pharmaceuticals had obligation activity on 2 federal contracts over the same 12 months, including 1 new contract. Agencies report contract actions with a delay, so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    -$5,360
    Obligations to revenue
    0.0%
    Prior 12 months$154,049
    Contracts with activity2
    New contracts1
    Average remaining term1.9 months

    12 months through Jul 31, 2026

    Largest New Awards

    Award IDAgencyAmountStartEndDescription
    36C26026F0025Department of Veterans Affairs$26,344Oct 1, 2025Sep 30, 2026PHARM - HETLIOZ
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first. All from the Department of Veterans Affairs.

    Monthly Obligations

    The latest complete month, Apr 2026, had no net obligations. The largest month in the table was Oct 2025, at $171,234.

    MonthObligations
    Jul 2026$0
    Jun 2026$0
    May 2026-$144,891
    Apr 2026$0
    Mar 2026$0
    Feb 2026-$31,703
    Jan 2026$0
    Dec 2025$0
    Nov 2025$0
    Oct 2025$171,234
    Sep 2025$0
    Aug 2025$0
    MonthObligations
    Jul 2025$0
    Jun 2025$0
    May 2025$0
    Apr 2025$0
    Mar 2025$0
    Feb 2025-$8,722
    Jan 2025$0
    Dec 2024$0
    Nov 2024$0
    Oct 2024$162,771
    Sep 2024$0
    Aug 2024$0

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About VNDA

    How much does Vanda Pharmaceuticals receive in federal contracts?

    Vanda Pharmaceuticals had -$5,360 in federal contract obligations over the 12 months through Jul 31, 2026, compared with $154,049 in the 12 months before. These were net de-obligations: agencies removed more from existing contracts than they added. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are Vanda Pharmaceuticals' largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were 36C26026F0025, Department of Veterans Affairs, $26,344, started Oct 1, 2025.

    What new federal contracts did Vanda Pharmaceuticals win in the 12 months through Jul 31, 2026?

    Vanda Pharmaceuticals won 1 new federal contract in the 12 months through Jul 31, 2026. The largest was 36C26026F0025, Department of Veterans Affairs, $26,344, started Oct 1, 2025.

    How do Vanda Pharmaceuticals' federal obligations compare with its revenue?

    Federal contract obligations were -$5,360 over the 12 months through Jul 31, 2026, equivalent to less than 1% of Vanda Pharmaceuticals' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Vanda Pharmaceuticals' revenue that comes from the government.